To Assess the Patients' Ability to Self-Administer Fasinumab

Clinical trial NCT03491904 · COMPLETED

Trial details

NCT number: NCT03491904
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Osteoarthritis, Knee Osteoarthritis, Hip

Start date: 2019-01-23
Primary completion: 2020-01-15
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.